Pemphigus Vulgaris: Causes, Symptoms, and Treatment Options

Introduction

Pemphigus vulgaris is a rare, chronic autoimmune disorder that affects both the skin and mucous membranes, leading to painful blisters and sores. First identified in the 18th century, this condition has been extensively studied due to its complex nature and significant health risks. While pemphigus vulgaris can be life-threatening if left untreated, advancements in medical treatments have greatly improved patient outcomes. This article provides a comprehensive overview of pemphigus vulgaris, including its risk factors, symptoms, diagnostic tests, treatment options, and self-care strategies. By understanding the condition and its management, patients can take an active role in their care, working closely with healthcare providers to manage symptoms and improve their quality of life.

What is Pemphigus Vulgaris?

Pemphigus vulgaris is a chronic autoimmune disease that causes painful blisters and sores on the skin and mucous membranes. This article will explore its risk factors, symptoms, diagnostic tests, medications, procedures, and home-care strategies to help manage the condition.

Description of Pemphigus Vulgaris

Pemphigus vulgaris is an autoimmune disorder in which the immune system mistakenly attacks healthy cells in the skin and mucous membranes. Specifically, it targets proteins called desmogleins, which are responsible for holding skin cells together. When these proteins are damaged, the skin cells separate, leading to the formation of blisters and sores. These blisters can develop on the skin, as well as inside the mouth, throat, nose, eyes, and even the genital area.

The progression of pemphigus vulgaris can vary. In some cases, it begins with mouth sores, which are often mistaken for canker sores. Over time, blisters may spread to other parts of the body, causing discomfort and increasing the risk of infection. Without treatment, pemphigus vulgaris can lead to serious complications, including dehydration, malnutrition, and sepsis (a life-threatening infection).

Pemphigus vulgaris is rare, affecting 1 to 5 people per million each year. It is most commonly diagnosed in middle-aged and older adults, though it can occur at any age. The condition is more prevalent in certain ethnic groups, including those of Mediterranean, Middle Eastern, and Ashkenazi Jewish descent.

Risk Factors for Developing Pemphigus Vulgaris

Lifestyle Risk Factors

Although pemphigus vulgaris is primarily an autoimmune disorder, certain lifestyle factors can worsen symptoms or trigger flare-ups. Stress is a well-known factor that can exacerbate autoimmune diseases, including pemphigus vulgaris. Emotional or physical stress weakens the immune system, increasing the likelihood of the body attacking its own tissues. Additionally, exposure to ultraviolet (UV) light, such as from sunbathing or tanning beds, may trigger skin blisters. Smoking and excessive alcohol consumption can also aggravate symptoms by impairing the body’s ability to heal and fight infections.

Medical Risk Factors

Individuals with a history of autoimmune diseases are at a higher risk of developing pemphigus vulgaris. Conditions such as rheumatoid arthritis, lupus, and myasthenia gravis are often seen in those with pemphigus vulgaris, suggesting a shared immune dysfunction. Certain medications, such as penicillamine (used for rheumatoid arthritis) and ACE inhibitors (used for high blood pressure), have been linked to triggering pemphigus vulgaris in some patients. Additionally, people who have undergone organ transplants or are on long-term immunosuppressive therapy may be more susceptible to developing autoimmune conditions like pemphigus vulgaris.

Genetic and Age-Related Risk Factors

Genetics play a significant role in the development of pemphigus vulgaris. Individuals with a family history of autoimmune disorders are more likely to develop the condition. Research has shown that certain genetic markers, particularly those related to the HLA (human leukocyte antigen) system, are associated with an increased risk of pemphigus vulgaris. This genetic predisposition is more common in specific ethnic groups, including Ashkenazi Jewish, Mediterranean, and Middle Eastern populations.

Age is another important factor. Pemphigus vulgaris is most commonly diagnosed in individuals between 40 and 60 years old, though it can occur at any age. Older adults may be at higher risk due to age-related changes in the immune system, which can make the body more prone to autoimmune attacks.

Clinical Manifestations of Pemphigus Vulgaris

Oral Blisters

Oral blisters are one of the earliest and most common signs of pemphigus vulgaris, affecting 50-70% of patients. These blisters appear on the mucous membranes inside the mouth and are often extremely painful. The immune system attacks desmogleins, causing skin cells in the mucous membranes to separate, leading to fluid-filled blisters. These blisters rupture easily, leaving painful sores that make eating and drinking difficult. Oral blisters may precede skin blisters by weeks or months, making them a crucial early indicator of the disease.

Skin Blisters

Skin blisters are another hallmark of pemphigus vulgaris, affecting 60-90% of patients. These blisters can appear anywhere on the skin but are most commonly found on the scalp, face, chest, back, and groin. Like oral blisters, skin blisters form when the immune system attacks desmogleins, causing skin cells to separate. The blisters are typically soft, flaccid, and filled with clear fluid. They rupture easily, leading to painful, open sores. Skin blisters may develop later in the disease, sometimes after oral blisters, but in some cases, they may be the first sign of pemphigus vulgaris.

Painful Sores

Painful sores, or erosions, occur when blisters rupture, leaving raw, exposed areas of skin or mucous membranes. These sores result from the immune system’s attack on desmogleins, causing skin layers to separate and form blisters that eventually break open. Painful sores are common in both the mouth and on the skin, significantly impacting a patient’s quality of life. Eating, drinking, and even talking can become difficult when oral sores are present. Skin sores can become infected if not properly cared for, complicating the healing process.

Crusted Lesions

Crusted lesions form when fluid from ruptured blisters dries, creating a crust over the affected area. These lesions are common in pemphigus vulgaris, affecting about 50% of patients. While crusting is part of the healing process, it can be uncomfortable and unsightly. Crusted lesions often appear on the scalp, face, and chest. In some cases, they may become infected, leading to further complications. Proper wound care is essential to prevent infection and promote healing.

Difficulty Swallowing

Difficulty swallowing, or dysphagia, affects 30-50% of patients with pemphigus vulgaris. This symptom occurs when blisters and sores develop in the throat and esophagus, making it painful and difficult to swallow food and liquids. The immune system’s attack on desmogleins in the throat’s mucous membranes leads to blister formation, which can rupture and cause raw, painful areas. If left untreated, difficulty swallowing can lead to malnutrition and weight loss, as patients may avoid eating due to discomfort.

Itching

Itching, or pruritus, affects 10-20% of patients with pemphigus vulgaris. Itching may occur around blisters or sores as the skin heals. The immune system’s attack on skin cells triggers inflammation, which can cause itching. In some cases, itching may indicate an allergic reaction to medications used to treat pemphigus vulgaris. Patients should inform their healthcare provider if they experience itching, as it can often be managed with topical treatments or medication adjustments.

Redness

Redness, or erythema, is a common sign of inflammation in pemphigus vulgaris, affecting 40-60% of patients. Redness occurs when the immune system attacks the skin and mucous membranes, causing inflammation and tissue damage. Affected areas may appear red and swollen, particularly around blisters and sores. Redness is often a sign of active immune system activity and may be accompanied by pain, itching, or warmth in the affected areas.

Erosion of Mucous Membranes

Erosion of the mucous membranes is a serious manifestation of pemphigus vulgaris, affecting up to 90% of patients. The mucous membranes line various parts of the body, including the mouth, throat, nose, and genitals. When the immune system attacks desmogleins in these areas, it causes the mucous membranes to break down, leading to painful erosions. These erosions can make eating, drinking, or speaking difficult and may become infected if not properly treated. Mucous membrane involvement is often one of the earliest signs of pemphigus vulgaris and can significantly impact a patient’s quality of life.

Fever

Fever is a less common symptom of pemphigus vulgaris, affecting 10-15% of patients. Fever may result from widespread inflammation or infection of the blisters and sores. In some cases, fever may indicate a secondary infection, such as a bacterial infection of the skin or mucous membranes. Patients with pemphigus vulgaris who develop a fever should seek medical attention, as it may signal a complication that requires treatment.

Weight Loss

Weight loss is a common complication of pemphigus vulgaris, affecting 30-50% of patients. This symptom is often due to difficulty eating caused by painful oral sores and difficulty swallowing. Additionally, the body’s increased metabolic demands during periods of inflammation and infection can contribute to unintentional weight loss. If left untreated, weight loss can lead to malnutrition and muscle wasting, further weakening the immune system and overall health. Addressing the causes of weight loss, such as managing oral sores and ensuring proper nutrition, is a crucial part of pemphigus vulgaris treatment.

Health Conditions with Similar Symptoms to Pemphigus Vulgaris

Bullous Pemphigoid

Definition: Bullous pemphigoid is an autoimmune skin disorder that leads to large, fluid-filled blisters, typically forming on areas that flex, such as the lower abdomen, upper thighs, or armpits. It occurs when the immune system mistakenly attacks the tissue just beneath the outer layer of the skin. This condition is most common in older adults and can cause significant discomfort.

How to Know if You Might Have Bullous Pemphigoid vs. Pemphigus Vulgaris

Both bullous pemphigoid and pemphigus vulgaris involve blistering, but there are important differences. In bullous pemphigoid, the blisters are larger and more tense, meaning they are firmer and less likely to rupture compared to the fragile blisters seen in pemphigus vulgaris. Bullous pemphigoid blisters often appear on the lower abdomen, thighs, and arms, while pemphigus vulgaris frequently affects mucous membranes, such as the mouth and throat.

Another distinction is that bullous pemphigoid blisters are often itchy, while pemphigus vulgaris blisters are typically painful but not itchy. A skin biopsy can help differentiate the two. In bullous pemphigoid, antibodies attack the basement membrane (the layer between the outer skin and underlying tissue), while in pemphigus vulgaris, antibodies target the connections between skin cells. Blood tests for specific antibodies can also help distinguish between these autoimmune blistering disorders.

Dermatitis Herpetiformis

Definition: Dermatitis herpetiformis is a chronic skin condition associated with celiac disease, an autoimmune disorder triggered by gluten. It causes clusters of small, intensely itchy blisters and bumps, often appearing on the elbows, knees, back, and buttocks. This condition results from the immune system reacting to gluten, leading to skin inflammation.

How to Know if You Might Have Dermatitis Herpetiformis vs. Pemphigus Vulgaris

While both dermatitis herpetiformis and pemphigus vulgaris can cause blistering, the appearance and location of the blisters differ. Dermatitis herpetiformis presents with smaller, intensely itchy blisters, often in clusters, and usually on the elbows, knees, back, and buttocks. In contrast, pemphigus vulgaris typically causes larger, painful blisters, especially in the mouth and other mucous membranes.

Itching is a hallmark of dermatitis herpetiformis, whereas pemphigus vulgaris is more associated with pain. To diagnose dermatitis herpetiformis, doctors may perform a skin biopsy and test for IgA antibodies in the skin. Blood tests for antibodies related to celiac disease may also be conducted. In contrast, pemphigus vulgaris is diagnosed by detecting antibodies against desmoglein, a protein that helps skin cells stick together.

Pemphigus Foliaceus

Definition: Pemphigus foliaceus is another autoimmune blistering disorder, but it primarily affects the upper layers of the skin, unlike pemphigus vulgaris, which affects deeper layers. This condition causes superficial blisters that are more likely to appear on the scalp, face, and chest. It typically does not involve mucous membranes, such as the mouth or throat.

How to Know if You Might Have Pemphigus Foliaceus vs. Pemphigus Vulgaris

Pemphigus foliaceus and pemphigus vulgaris are both forms of pemphigus, but they affect different layers of the skin. In pemphigus foliaceus, the blisters are more superficial and tend to appear on the scalp, face, and chest, whereas pemphigus vulgaris blisters are deeper and often involve mucous membranes, such as the mouth and throat.

Blisters in pemphigus foliaceus are less likely to cause pain and are more likely to be itchy, while pemphigus vulgaris blisters are typically painful. A skin biopsy can help differentiate between the two conditions. In pemphigus foliaceus, the biopsy will show antibodies attacking the outermost layers of the skin, while in pemphigus vulgaris, the antibodies target deeper layers. Blood tests can also detect specific antibodies unique to each condition.

Contact Dermatitis

Definition: Contact dermatitis is a skin reaction that occurs when the skin comes into contact with an irritant or allergen. It causes redness, itching, and sometimes blistering in the areas exposed to the substance. Common triggers include soaps, detergents, plants like poison ivy, and certain metals like nickel.

How to Know if You Might Have Contact Dermatitis vs. Pemphigus Vulgaris

Both contact dermatitis and pemphigus vulgaris can cause blistering, but the triggers and symptoms differ. Contact dermatitis occurs after direct contact with an irritant or allergen, and symptoms are usually confined to the area of contact. The blisters in contact dermatitis are typically smaller and accompanied by redness, itching, and swelling.

In contrast, pemphigus vulgaris does not require exposure to an external substance and often involves mucous membranes, such as the mouth or throat. Contact dermatitis is usually diagnosed based on a history of exposure to a potential irritant or allergen, and patch testing can identify the specific trigger. Pemphigus vulgaris is diagnosed through skin biopsies and blood tests that detect antibodies against skin cell proteins.

Lichen Planus

Definition: Lichen planus is an inflammatory condition that affects the skin, hair, nails, and mucous membranes. It causes flat, purple, itchy bumps on the skin and painful sores in the mouth or other mucous membranes. The exact cause of lichen planus is unknown, but it is thought to be related to an abnormal immune response.

How to Know if You Might Have Lichen Planus vs. Pemphigus Vulgaris

Lichen planus and pemphigus vulgaris can both affect mucous membranes, particularly the mouth, but the appearance of the lesions is different. Lichen planus causes flat, purple, itchy bumps on the skin and white, lacy patches or painful sores in the mouth, while pemphigus vulgaris causes larger, painful blisters.

Itching is more common in lichen planus, while pain is more common in pemphigus vulgaris. A skin biopsy can help differentiate between the two conditions. In lichen planus, the biopsy will show inflammation in the deeper layers of the skin and mucous membranes, while in pemphigus vulgaris, the biopsy will show antibodies attacking the connections between skin cells. Blood tests for specific antibodies can also help distinguish between the two conditions.

Erythema Multiforme

Definition: Erythema multiforme is a hypersensitivity reaction that causes red, target-shaped lesions on the skin. It is often triggered by infections, such as herpes simplex virus, or medications. The condition can range from mild to severe and may also involve the mucous membranes, causing painful sores.

How to Know if You Might Have Erythema Multiforme vs. Pemphigus Vulgaris

Erythema multiforme and pemphigus vulgaris can both cause lesions on the skin and mucous membranes, but the appearance of the lesions is different. Erythema multiforme causes red, target-shaped lesions, while pemphigus vulgaris causes blisters. Erythema multiforme is often triggered by infections or medications, whereas pemphigus vulgaris is an autoimmune condition with no external trigger.

A skin biopsy can help differentiate between the two conditions. In erythema multiforme, the biopsy will show inflammation and damage to the blood vessels in the skin, while in pemphigus vulgaris, the biopsy will show antibodies attacking the connections between skin cells. Blood tests can also help distinguish between the two conditions.

Drug-Induced Pemphigus

Definition: Drug-induced pemphigus is a rare condition in which certain medications trigger the development of blisters similar to those seen in pemphigus vulgaris. The medications most commonly associated with drug-induced pemphigus include penicillamine, ACE inhibitors, and certain antibiotics.

How to Know if You Might Have Drug-Induced Pemphigus vs. Pemphigus Vulgaris

Drug-induced pemphigus and pemphigus vulgaris share many similarities, including the presence of blisters on the skin and mucous membranes. However, drug-induced pemphigus is triggered by specific medications, whereas pemphigus vulgaris occurs without any external trigger. If you have recently started a new medication and develop blisters, drug-induced pemphigus may be the cause.

To diagnose drug-induced pemphigus, your doctor will review your medication history and may perform a skin biopsy to look for the same antibodies seen in pemphigus vulgaris. Stopping the medication usually leads to improvement in drug-induced pemphigus, whereas pemphigus vulgaris requires ongoing treatment to manage the autoimmune response.

Treatment Options for Pemphigus Vulgaris

Medications

Corticosteroids: Corticosteroids are anti-inflammatory medications that help suppress the immune system’s response, which is responsible for the blistering in pemphigus vulgaris. They can be taken orally or applied topically.

Corticosteroids are often the first-line treatment for pemphigus vulgaris, especially in moderate to severe cases. They are typically used when the disease is active to bring it under control quickly. Long-term use may be avoided due to the risk of side effects.

Patients can expect a reduction in blistering and inflammation within weeks, though the full effect may take longer. However, corticosteroids are usually tapered off once symptoms are controlled to minimize side effects.

Azathioprine: Azathioprine is an immunosuppressant that reduces the activity of the immune system, helping to prevent the formation of new blisters.

Azathioprine is often used in combination with corticosteroids to reduce the steroid dosage needed. It is typically prescribed for patients who require long-term maintenance therapy or when corticosteroids alone are insufficient.

Patients may notice a gradual improvement over several weeks to months. The goal is to control the disease while minimizing the need for high-dose corticosteroids.

Mycophenolate mofetil: Mycophenolate mofetil is another immunosuppressant that works by inhibiting the production of immune cells responsible for attacking the skin in pemphigus vulgaris.

This medication is often used as a second-line treatment, particularly in patients who cannot tolerate azathioprine or corticosteroids. It is also used for long-term management to maintain remission.

Improvement may take several weeks to months, and the medication can help reduce the frequency of flare-ups over time.

Rituximab: Rituximab is a biologic therapy that targets specific immune cells (B-cells) responsible for producing the antibodies that attack the skin in pemphigus vulgaris.

Rituximab is usually reserved for patients with moderate to severe disease who do not respond well to corticosteroids or other immunosuppressants. It is administered as an intravenous infusion.

Many patients experience significant improvement within a few months, and some may achieve long-term remission. Rituximab has been shown to be highly effective in reducing disease activity.

Dapsone: Dapsone is an anti-inflammatory medication that also has antibacterial properties. It helps reduce the immune system’s attack on the skin in pemphigus vulgaris.

Dapsone is typically used in mild cases or as an adjunct therapy to other medications. It may be prescribed for patients who cannot tolerate stronger immunosuppressants.

Patients may experience a reduction in symptoms within weeks, though the full effect may take longer. Dapsone is generally well-tolerated but requires regular monitoring for side effects.

Cyclophosphamide: Cyclophosphamide is a potent immunosuppressant that works by reducing the activity of the immune system, helping to control the blistering in pemphigus vulgaris.

This medication is generally reserved for severe cases that do not respond to other treatments. It is often used in combination with corticosteroids to reduce the need for high steroid doses.

Improvement may take several weeks to months, and cyclophosphamide can help bring the disease under control in difficult-to-treat cases. However, it carries a higher risk of side effects.

Intravenous immunoglobulin (IVIG): Intravenous immunoglobulin (IVIG) is a therapy that involves administering antibodies from healthy donors to help neutralize the harmful antibodies causing pemphigus vulgaris.

IVIG is typically used in patients with severe disease or those who do not respond to standard treatments. It is administered through an intravenous infusion over several hours.

Patients may experience improvement within a few weeks, and IVIG can help reduce the frequency and severity of flare-ups. It is often used as a short-term treatment during active disease.

Tacrolimus: Tacrolimus is a topical immunosuppressant that helps reduce inflammation and immune activity in the skin.

Tacrolimus is usually used for localized or mild cases of pemphigus vulgaris, particularly when oral medications are not necessary. It is applied directly to affected areas of the skin.

Patients may notice a reduction in blistering and inflammation within a few weeks of use. Tacrolimus is generally well-tolerated and can be used long-term for maintenance.

Methotrexate: Methotrexate is an immunosuppressant that reduces the activity of the immune system, helping to control the blistering in pemphigus vulgaris.

This medication is often used in patients who do not respond to corticosteroids or other immunosuppressants. It can be used for long-term management to maintain remission.

Improvement may take several weeks to months, and methotrexate can help reduce the need for high-dose corticosteroids.

Plasmapheresis: Plasmapheresis is a procedure that removes harmful antibodies from the blood, helping to reduce the immune system’s attack on the skin in pemphigus vulgaris.

This procedure is typically reserved for severe cases that do not respond to medications. It is often used in combination with other treatments, such as corticosteroids or immunosuppressants.

Patients may experience improvement within a few weeks, though multiple sessions may be required. Plasmapheresis can help bring the disease under control in difficult-to-treat cases.

Improving Pemphigus Vulgaris and Seeking Medical Help

In addition to medical treatments, several home remedies may help soothe the symptoms of pemphigus vulgaris and improve your quality of life:

1. Aloe vera: Known for its soothing properties, aloe vera can help reduce inflammation and promote healing when applied to the skin.
2. Coconut oil: This natural moisturizer can help keep the skin hydrated and reduce irritation.
3. Chamomile tea: Chamomile has anti-inflammatory properties and can be applied topically to soothe irritated skin.
4. Turmeric: Known for its anti-inflammatory effects, turmeric can be used in cooking or as a topical paste to help reduce inflammation.
5. Honey: Honey has natural antibacterial properties and can be applied to blisters to help prevent infection.
6. Oatmeal baths: Oatmeal can help soothe itchy and irritated skin when added to a bath.
7. Vitamin E oil: This oil can help promote skin healing and reduce scarring.
8. Avoiding spicy foods: Spicy foods can irritate mouth sores, so it’s best to avoid them during flare-ups.
9. Staying hydrated: Drinking plenty of water can help keep your skin hydrated and promote healing.
10. Stress management: Stress can trigger flare-ups, so practicing relaxation techniques like meditation or yoga may help reduce symptoms.

While home remedies can provide some relief, it’s essential to seek medical help if your symptoms worsen or if you experience new symptoms. Telemedicine offers a convenient way to consult with a healthcare provider from the comfort of your home, ensuring timely care and management of your condition.

Living with Pemphigus Vulgaris: Tips for Better Quality of Life

Living with pemphigus vulgaris can be challenging, but there are steps you can take to improve your quality of life:

1. Follow your treatment plan: Adhering to your prescribed medications and treatments is essential for managing symptoms and preventing flare-ups.
2. Maintain good skin care: Use gentle, fragrance-free cleansers and moisturizers to keep your skin hydrated and avoid irritation.
3. Eat a balanced diet: A healthy diet rich in vitamins and minerals can support your immune system and promote healing.
4. Stay active: Regular physical activity can help reduce stress and improve your overall well-being. Just be mindful of any skin irritation that may occur during exercise.
5. Manage stress: Stress can trigger flare-ups, so finding ways to relax and manage stress is crucial. Consider activities like meditation, yoga, or deep breathing exercises.
6. Stay connected: Support from family, friends, or a support group can provide emotional comfort and help you cope with the challenges of living with a chronic condition.

Conclusion

Pemphigus vulgaris is a rare autoimmune skin disorder that causes painful blisters on the skin and mucous membranes. Early diagnosis and treatment are crucial for managing the disease and preventing complications. With the right combination of medications and lifestyle adjustments, many patients can achieve remission and lead a fulfilling life.

If you suspect you have symptoms of pemphigus vulgaris, don’t hesitate to seek medical help. Our telemedicine practice offers convenient, accessible care from the comfort of your home. Early intervention can make a significant difference in your treatment outcomes, so schedule a consultation with one of our primary care providers today.

James Kingsley

Learn More